Prophylactic Lamivudine Administration Prevents Exacerbation of Liver Damage in HBe Antigen Positive Patients with Hepatocellular Carcinoma Undergoing Transhepatic Arterial Infusion Chemotherapy-Reference-Cited by-同舟云学术

Prophylactic Lamivudine Administration Prevents Exacerbation of Liver Damage in HBe Antigen Positive Patients with Hepatocellular Carcinoma Undergoing Transhepatic Arterial Infusion Chemotherapy

Published:2004-12 Issue:12 Volume:99 Page:2369-2375
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterology

Author:

Nagamatsu Hiroaki,Itano Satoshi,Nagaoka Sakae,Akiyoshi Junji,Matsugaki Satoru,Kurogi Junichi,Tajiri Nobuyoshi,Yamasaki Sanki,Koga Hironori,Torimura Takuji,Kumashiro Ryukichi,Sata Michio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference39 articles.

1. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization.

2. Radioimmunotherapy for unresectable hepatocellular carcinoma using131I-Hepama-1 mAb: preliminary results

3. Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system

4. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma;Journal of Liver Cancer;2023-03-31

2. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma;Clinical and Molecular Hepatology;2022-10-01

3. KASL clinical practice guidelines for management of chronic hepatitis B;Clinical and Molecular Hepatology;2022-04-01

4. 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma;Korean Journal of Radiology;2022

5. Association of Virological Response to Antiviral Therapy With Survival in Intermediate-Stage Hepatitis B Virus-Related Hepatocellular Carcinoma After Chemoembolization;Frontiers in Oncology;2021-10-22